Literature DB >> 9128971

Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging.

M A Moerland1, H K Wijrdeman, R Beersma, C J Bakker, J J Battermann.   

Abstract

PURPOSE: The aim of this study is the evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging (MRI). METHODS AND MATERIALS: Twenty-one patients underwent radiography on the simulator and MRI within 3 days after implantation of the I-125 seeds. Isocentric radiographs were used for reconstruction of the seed distribution, after which registration with the seed-induced signal voids on MRI provided the seed positions in relation to the prostate. The prostate was contoured on the transversal magnetic resonance images, and dose-volume histograms were computed to evaluate the implants. The validity of the ellipsoidal prostate volume approximation, as applied in preimplant dose calculation, was assessed by comparison of ellipsoidal volumes given by prostate width, height, and length and prostate volumes obtained by a slice-by-slice contouring method, both on postimplant MRI. Prostate volume changes due to postimplant prostate swelling were assessed from radiographs taken at 3 days and 1 month after the implantation.
RESULTS: The seeds were readily identified on T1-weighted spin-echo images and matched with the seed distribution reconstructed from the isocentric radiographs. The matching error, averaged over 21 patients, amounted to 1.8 +/- 0.4 mm (mean +/- standard deviation). The fractions of the prostate volumes receiving the prescribed matched peripheral dose (MPD) ranged from 32 to 71% (mean +/- standard deviation: 60 +/- 10%). Prostate volumes, obtained by the contouring method on postimplant MRI, were a factor 1.5 +/- 0.3 larger than the ellipsoidal volumes given by the prostate dimensions on postimplant MRI. Prostate volumes 3 days after the implantation were a factor 1.3 +/- 0.2 larger than the prostate volumes 1 month after the implantation. Registration of the reconstructed seed distribution and the MR images showed inaccuracies in seed placement, for example, two or more seeds clustering together or seeds outside the prostate.
CONCLUSIONS: Registration of the reconstructed seed distribution and the MR images enabled evaluation of target coverage, which amounted to 60 +/- 10%. The discrepancy between prescribed dose and realized dose was caused by underestimation of the preimplant prostate volume due to the ellipsoidal approximation, postimplant prostate swelling at the time of evaluation, and inaccuracies in seed placement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128971     DOI: 10.1016/s0360-3016(96)00575-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

1.  Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds.

Authors:  Manabu Aoki; Atsunori Yorozu; Takushi Dokiya
Journal:  Jpn J Radiol       Date:  2009-12-25       Impact factor: 2.374

2.  Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.

Authors:  Manabu Aoki; Atsunori Yorozu; Takushi Dokiya
Journal:  Jpn J Radiol       Date:  2009-11-27       Impact factor: 2.374

3.  Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.

Authors:  Jingfei Ma; Marinus A Moerland; Aradhana M Venkatesan; Tharakeswara K Bathala; Rajat J Kudchadker; Kristy K Brock; Steven J Frank
Journal:  Brachytherapy       Date:  2017-01-04       Impact factor: 2.362

4.  Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.

Authors:  Tze Yee Lim; Rajat J Kudchadker; Jihong Wang; R Jason Stafford; Christopher MacLellan; Arvind Rao; Geoffrey S Ibbott; Steven J Frank
Journal:  Med Phys       Date:  2016-07       Impact factor: 4.071

5.  The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers.

Authors:  Zhe Jay Chen; Kenneth Roberts; Roy Decker; Pradip Pathare; Sara Rockwell; Ravinder Nath
Journal:  Phys Med Biol       Date:  2011-07-19       Impact factor: 3.609

6.  On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.

Authors:  Z Jay Chen; Jun Deng; Kenneth Roberts; Ravinder Nath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-05       Impact factor: 7.038

Review 7.  Magnetic resonance image guided brachytherapy.

Authors:  Kari Tanderup; Akila N Viswanathan; Christian Kirisits; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

Review 8.  Permanent interstitial brachytherapy for prostate cancer: a current review.

Authors:  Jeffrey Woolsey; Nicole Miller; Dan Theodorescu
Journal:  World J Urol       Date:  2003-08-13       Impact factor: 4.226

Review 9.  Alternative therapies for localized prostate cancer.

Authors:  Harrie P Beerlage
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

10.  A magnetic resonance-based seed localization method for I-125 prostate implants.

Authors:  Rena J Lee; Hyun Suk Suh; Kyung Ja Lee; Soome Lim; Yookyung Kim; Sungkyu Kim; Jinho Choi
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.